Zobrazeno 1 - 3
of 3
pro vyhledávání: '"RC Khan"'
Autor:
Ali, RC Khan, TC Ghose, Khq Islam, K Pasha, FM Siddiqui, TF Khan, AK Choudhury, Aqm Reza, R S Mahmud, Stm Abu Azam, M. Ali, SK Basak, MN Islam, M. M. Rahman, MA Bashar, J Ahmed, Mak Akanda, Aas Majumder, M Sadequzzaman
Publikováno v:
Cardiovascular Journal. 5:44-50
Background: The CONTROL (COversyl in Newly diagnosed stage-II & unconTROlled hypertensivepatients triaL) was performed with an objective to evaluate the blood pressure (BP) lowering efficacyand tolerability of Perindopril 8mg in newly diagnosed stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6bf08983ce1978cb60245cc0978156a
https://doi.org/10.3329/cardio.v5i1.12272
https://doi.org/10.3329/cardio.v5i1.12272
Autor:
Clayton NP; Global Rare Diseases, Sanofi Genzyme, Cambridge, Massachusetts., Khan-Malek RC; Global Biostatistics and Programming, Sanofi, Bridgewater, New Jersey., Dangler CA; Preclinical Safety, Sanofi, Framingham, Massachusetts., Zhang D; Global Biostatistics and Programming, Sanofi, Bridgewater, New Jersey., Ascah A; Liminal Biosciences, Laval, Canada., Gains M; Liminal Biosciences, Laval, Canada., Gardner B; Partner Therapeutics, Inc, Lexington, Massachusetts., Mockbee C; Partner Therapeutics, Inc, Lexington, Massachusetts., Keutzer JM; Global Rare Diseases, Sanofi Genzyme, Cambridge, Massachusetts., McManus J; Partner Therapeutics, Inc, Lexington, Massachusetts., Authier S; Charles River Laboratories, Laval, Canada.
Publikováno v:
Radiation research [Radiat Res] 2021 Feb 01; Vol. 195 (2), pp. 191-199.